Background -Several studies have suggested that the respiratory muscles are weak in patients with heart failure, but the aetiology and clinical relevance of this weakness are unclear. In order to see if respiratory muscle weakness in this context is part of a more generalised myopathic process, respiratory and limb muscle strength were compared in patients with heart failure. The relation between respiratory muscle strength, breathlessness on exercise, and exercise capacity was also examined.
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Methods -Twenty patients (three women) with New York Heart Association (NYHA) class II-IV heart failure of mean age 63 years were studied. Respiratory muscle strength was assessed using maximum inspiratory and expiratory mouth pressures (MIP and MEP) and transdiaphragmatic pressure during sniffs (sniff PDI). These parameters were compared with cardiac output (indirect Fick) and with limb muscle strength as assessed by grip strength. The patients also performed two exercise tests during which they rated their breathlessness on a Borg scale. Results -Mean (SD) cardiac index was 2-2 (0 4) I/min/m2. MIP We have therefore studied respiratory muscle strength in patients with heart failure and looked to see if weakness is related to poor cardiac output. We have also compared respiratory and limb muscle strength in these patients to see if respiratory muscle weakness is part of a generalised myopathic process. Finally, we have investigated whether respiratory muscle strength is related to either exercise capacity or dyspnoea on exercise.
Methods

PATIENTS
Twenty patients with chronic heart failure (three women) with a mean age of 63 years were studied. The mean (SD) height and weight were 1-69 (005) m and 73-6 (106) kg respectively. All gave informed consent to the study, which was approved by the hospital ethical committee. The aetiology of heart failure was ischaemic heart disease (n = 14), valvular lesions (n = 2), hypertension (n = 2) or dilated cardiomyopathy (n = 2). All patients had an enlarged heart on chest radiography and echocardiographic evidence of impaired left ventricular function. Their New York Heart Association (NYHA) classification ofheart failure severity was II (n=8), III (n= 10) or IV (n = 2). All were taking diuretics, 13 angiotensin converting enzyme inhibitors and three digoxin. Resting cardiac output was measured by the indirect Fick principle, using carbon dioxide as the indicator. Ventilation and mixed expired carbon dioxide concentrations were measured with the subject at rest using the same equipment as in the exercise tests. Carbon dioxide production was measured over one minute, during which time arterial carbon dioxide tension was estimated from the end tidal concentration. Mixed venous carbon dioxide tension was then estimated by asking the subject to rebreathe from an anaesthetic bag, initially containing 10% carbon dioxide. This method of calculation of cardiac output has been shown to correlate well in our laboratory with the thermodilution technique.' DATA ANALYSIS Statistical comparisons were made using the FASTAT package on a microcomputer, taking 0 05 as the level of statistical significance. Comparisons of mean values with normal range data were made using unpaired t tests. Spearman rank order correlation coefficients were used to investigate the relationship between indices of respiratory muscle strength and the other variables measured. Results are expressed as mean (SD). 
Results
108
We did not confirm this finding. Interestingly, their study showed that dyspnoea was the iation; LVEF = left ventricular ejection fraction; Vo2max = symptom which limited exercise in 50% of MIP = maximum inspiratory pressure; MEP = maximum normal subjects and the same proportion of patients with mitral stenosis. This was the case in only 20% of patients with heart failure from other causes, fatigue being a more common limiting symptom. This finding suggests that perhaps patients with long standing valvular heart disease, such as those studied by De
Troyer et al,' should be considered separately when evaluating respiratory muscle function in heart failure. Breathlessness may be less important in heart failure from other causes, and in any case is likely to be multifactorial in origin. Our data suggest that respiratory muscle strength is not one of these factors.
In conclusion, we confirm that the respiratory muscles are indeed weak in patients with chronic heart failure, and that this weakness is related to cardiac output. The weakness reflects a global myopathy with respiratory and limb muscle strength being reduced in proportion. Simple tests of strength suggest that respiratory muscle weakness neither limits exercise capacity nor, indeed, is involved in the aetiology of breathlessness on exercise. More work is needed on respiratory muscle endurance in heart failure, and paired measurements of strength and endurance before and after treatment should also be performed. When these data are available it should be apparent whether or not specific interventions to improve respiratory muscle function -for example, endurance training regimes -are likely to be worthwhile in alleviating symptoms in patients with heart failure. Respiratory muscle weakness appears not to limit exercise capacity or, indeed, to be involved in the aetiology of breathlessness on exercise.
